Overview of Gestational Trophoblastic Disease

Gestational Trophoblastic Disease (GTD) encompasses a group of rare tumors that involve abnormal growth of cells inside a woman’s uterus. These tumors originate from the cells that would typically form the placenta during pregnancy. Understanding GTD's symptoms, causes, classification, diagnosis, treatment, and prevention is crucial for effective management.

---

Classification of Gestational Trophoblastic Disease

GTD is classified into several types based on the nature and behavior of the abnormal cell growth. The main categories include:

Hydatidiform Mole (Molar Pregnancy)

Hydatidiform mole, commonly known as molar pregnancy, is subdivided into complete and partial moles. A complete mole occurs when an empty egg is fertilized by a sperm, leading to the absence of fetal tissue. In contrast, a partial mole happens when two sperm fertilize a normal egg, resulting in abnormal fetal tissue and placental growth.

Invasive Mole

An invasive mole, also known as chorioadenoma destruens, arises when the molar tissue grows into the muscular layer of the uterus. This type can invade other tissues and is more aggressive than a simple molar pregnancy.

Choriocarcinoma

Choriocarcinoma is a malignant form of GTD that can spread to other parts of the body, including the lungs, liver, and brain. It usually develops after a molar pregnancy but can also follow a normal pregnancy, miscarriage, or abortion.

Placental Site Trophoblastic Tumor (PSTT)

PSTT is a rare form of GTD that grows at the site where the placenta attaches to the uterine wall. It can occur after any type of pregnancy and tends to grow slowly but can invade the uterine muscle and spread to other organs.

Epithelioid Trophoblastic Tumor (ETT)

ETT is even rarer than PSTT and involves the proliferation of intermediate trophoblastic cells. It tends to occur years after a pregnancy and can spread to other parts of the body.

---

Causes of Gestational Trophoblastic Disease

The exact causes of GTD remain unclear, but some factors are thought to contribute to its development:

Genetic Factors

Genetic abnormalities are a significant contributor. For instance, a complete mole typically has only paternal chromosomes due to the fertilization of an empty egg.

Previous Molar Pregnancy

Women who have had a molar pregnancy are at a higher risk of developing GTD in subsequent pregnancies.

Age

Age plays a role, with women under 20 or over 35 being more susceptible to molar pregnancies.

Nutritional Deficiencies

Certain studies suggest that deficiencies in carotene and vitamin A may increase the risk of GTD.

---

Gestational Trophoblastic Disease Symptoms

Recognizing the symptoms of GTD is essential for early diagnosis and treatment. The symptoms can vary depending on the type of GTD but commonly include:

Vaginal Bleeding

Vaginal bleeding during pregnancy, especially in the first trimester, is a common symptom of GTD. It may be light spotting or heavy bleeding and can be mistaken for a miscarriage.

Rapid Uterine Growth

The uterus may grow faster than expected for the gestational age, leading to a larger-than-normal abdomen.

Severe Nausea and Vomiting

Hyperemesis gravidarum, characterized by severe nausea and vomiting, is more prevalent in GTD due to high levels of human chorionic gonadotropin (hCG).

High hCG Levels

Elevated hCG levels that do not correlate with the gestational age can indicate GTD. Persistent high levels post-pregnancy are particularly concerning.

Pelvic Pain and Pressure

Pain and pressure in the pelvic region may occur due to the abnormal growth of trophoblastic tissue.

Preeclampsia Symptoms

Pre-eclampsia, including high blood pressure and protein in urine, may develop earlier than usual in GTD cases.

---

Diagnosis of Gestational Trophoblastic Disease

Early diagnosis of GTD is crucial for effective treatment and management. Diagnostic procedures include:

Ultrasound

An ultrasound scan is typically the first step in diagnosing GTD. A complete mole may show a “snowstorm” pattern with no fetal development, while a partial mole may show some fetal tissue alongside the abnormal placental tissue.

hCG Measurement

Blood tests to measure hCG levels are essential. Abnormally high or plateauing hCG levels can indicate GTD.

Histopathological Examination

A definitive diagnosis is often made through the histopathological examination of tissue obtained via dilation and curettage (D&C).

Imaging Studies

Further imaging studies, such as chest X-rays, CT scans, or MRI, may be required to check for the spread of GTD to other organs.

---

Treatment for Gestational Trophoblastic Disease

Treatment depends on the type and extent of GTD. Options include:

Surgical Treatment

Dilation and curettage (D&C) is a common procedure to remove molar tissue from the uterus. In some cases, a hysterectomy (removal of the uterus) may be necessary, especially in older women who do not wish to preserve fertility.

Chemotherapy

Chemotherapy is the mainstay treatment for malignant forms of GTD, such as choriocarcinoma and invasive moles. Single-agent chemotherapy (e.g., methotrexate) is used for low-risk cases, while multi-agent chemotherapy is reserved for high-risk or metastatic disease.

Radiation Therapy

Radiation therapy may be used in rare cases where GTD has spread to the brain or other critical areas.

Follow-Up Care

Regular follow-up care is crucial to monitor hCG levels and ensure complete remission. This often includes monthly hCG measurements for at least six months to a year after treatment.

---

Prevention of Gestational Trophoblastic Disease

While it's challenging to prevent GTD entirely, certain measures can reduce the risk:

Regular Prenatal Care

Regular prenatal visits allow for early detection of abnormalities in pregnancy.

Genetic Counseling

Women with a history of molar pregnancies may benefit from genetic counseling before future pregnancies.

Nutritional Support

Ensuring adequate intake of carotene and vitamin A may help reduce the risk.